NEWS
Onvansertib Induces Anti-Leukemic Activity at Higher Doses in Relapsed/Refractory Acute Myeloid Leukemia
| Targeted Oncology

Higher dose levels of onvansertib in combination with decitabine (Dacogen) demonstrated durable responses as treatment of patients with relapsed/refractory acute myeloid leukemia (AML), and the agent also had anti-leukemic activity and appeared well-tolerated, according to final phase 1b and preliminary phase 2 results presented during the virtual 25th Congress of the European Hematology Association (EHA).1 […]

CFO brings repeat-business mindset, honed at Amazon Prime, to cancer-testing startup
| CFO Dive

No one was happy when the cost of an Amazon Prime subscription increased from $79 to $100 six years ago, but it was a decision Amazon made to keep Prime one of its biggest growth engines. “That was me,” Aarif Nakhooda, who was CFO of Worldwide Amazon Prime at the time, told CFO Dive. “That was […]

La Jolla biotech firm looking at obesity connection to Alzheimer’s
| La Jolla Light

La Jolla-based INmune Bio is exploring the connection between obesity and Alzheimer’s disease. Chief Executive Dr. RJ Tesi said the immuno-oncology company is looking at chronic inflammation, which, when present with neuroinflammation, can contribute to conditions such as Alzheimer’s. Though chronic inflammation “sounds as benign as white bread,” it is “a terrible disease that many of us […]